BLDEW (Blade Air Mobility, Inc. Warrants)
Insider Trading Activity
Every open-market purchase and sale reported by BLDEW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-18 | Scott M Wunsch | CEO, Trinity Air Medical | A | — | — |
| 2025-08-07 | ROBERT S WIESENTHAL | Chief Executive Officer | M | — | — |
| 2025-08-07 | Melissa M. Tomkiel | President and General Counsel | M | — | — |
| 2025-08-05 | Reginald Love | Director | A | — | — |
| 2025-08-05 | ANDREW LAUCK | Director | A | — | — |
| 2025-08-05 | Eric Affeldt | Director | A | — | — |
| 2025-08-05 | William A. Heyburn | Chief Financial Officer | MIXED | — | — |
| 2025-08-05 | John Borthwick | Director | A | — | — |
| 2025-08-05 | EDWARD M PHILIP | Director | A | — | — |
| 2025-08-05 | KENNETH B LERER | Director | A | — | — |
| 2025-08-05 | Susan M Lyne | Director | A | — | — |
| 2025-08-05 | Amir Cohen | Chief Accounting Officer | MIXED | — | — |
| 2025-08-05 | Melissa M. Tomkiel | President and General Counsel | MIXED | — | — |
| 2025-08-05 | ROBERT S WIESENTHAL | Chief Executive Officer | MIXED | — | — |
| 2025-06-11 | ROBERT S WIESENTHAL | Chief Executive Officer | F | — | — |
| 2025-06-11 | William A. Heyburn | Chief Financial Officer | MIXED | — | — |
| 2025-06-11 | Amir Cohen | Chief Accounting Officer | F | — | — |
| 2025-06-11 | Melissa M. Tomkiel | President and General Counsel | MIXED | — | — |
| 2025-06-11 | Scott M Wunsch | CEO, Trinity Air Medical | F | — | — |
| 2025-05-07 | ANDREW LAUCK | Director | A | — | — |
| 2025-05-07 | Scott M Wunsch | CEO, Trinity Air Medical | A | — | — |
| 2025-03-28 | ROBERT S WIESENTHAL | Chief Executive Officer | MIXED | — | — |
| 2025-03-28 | Melissa M. Tomkiel | President and General Counsel | M | — | — |
| 2025-03-17 | Amir Cohen | Chief Accounting Officer | MIXED | — | — |
| 2025-03-17 | ROBERT S WIESENTHAL | Chief Executive Officer | MIXED | — | — |
| 2025-03-17 | Scott M Wunsch | CEO, Trinity Air Medical | MIXED | — | — |
| 2025-03-17 | William A. Heyburn | Chief Financial Officer | MIXED | — | — |
| 2025-03-17 | Melissa M. Tomkiel | President and General Counsel | MIXED | — | — |
| 2025-03-17 | Scott M Wunsch | CEO, Trinity Air Medical | MIXED | — | — |
| 2025-01-10 | Melissa M. Tomkiel | President and General Counsel | M | — | — |
| 2025-01-08 | William A. Heyburn | Chief Financial Officer | MIXED | — | — |
| 2024-12-23 | William A. Heyburn | Chief Financial Officer | M | — | — |
| 2024-12-23 | ROBERT S WIESENTHAL | Chief Executive Officer | MIXED | — | — |
| 2024-12-17 | John Borthwick | Director | MIXED | — | — |
| 2024-12-17 | Reginald Love | Director | Sell | — | — |
| 2024-12-11 | Amir Cohen | Chief Accounting Officer | F | — | — |
| 2024-12-11 | Scott M Wunsch | CEO, Trinity Air Medical | F | — | — |
| 2024-12-11 | Melissa M. Tomkiel | President and General Counsel | MIXED | — | — |
| 2024-12-11 | William A. Heyburn | Chief Financial Officer | MIXED | — | — |
| 2024-12-11 | ROBERT S WIESENTHAL | Chief Executive Officer | F | — | — |
| 2024-12-04 | Amir Cohen | Chief Accounting Officer | Sell | — | — |
| 2024-12-03 | William A. Heyburn | Chief Financial Officer | Sell | — | — |
| 2024-12-03 | Eric Affeldt | Director | G | — | — |
| 2024-12-03 | Eric Affeldt | Director | — | — | — |
| 2024-11-29 | Melissa M. Tomkiel | President and General Counsel | Sell | — | — |
| 2024-11-19 | William A. Heyburn | Chief Financial Officer | M | — | — |
| 2024-11-15 | ROBERT S WIESENTHAL | Chief Executive Officer | Sell | — | — |
| 2024-11-13 | Melissa M. Tomkiel | President and General Counsel | Sell | — | — |
| 2024-09-13 | ROBERT S WIESENTHAL | Chief Executive Officer | F | — | — |
| 2024-09-13 | Amir Cohen | Chief Accounting Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 6,155,535 | — |
| — | Director | 3,127,284 | — |
| — | 10%+ Owner | 2,005,000 | — |
| — | Chief Financial Officer | 1,463,940 | — |
| — | CEO, Trinity Air Medical | 1,351,552 | — |
| — | President and General Counsel | 1,169,334 | — |
| — | CEO, Trinity Air Medical | 687,008 | — |
| — | Director | 581,214 | — |
| — | Chief Innovation Officer | 338,589 | — |
| — | Director | 234,165 | — |
| — | Director | 223,696 | — |
| — | Director | 203,977 | — |
| — | Director | 187,185 | — |
| — | Director | 135,897 | — |
| — | Director | 118,798 | — |
| — | Director | 118,276 | — |
| — | Chief Technology Officer | 111,754 | — |
| — | Chief Accounting Officer | 91,916 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BLDEW quote page; the site-wide leaderboard is on the insider transactions hub.